Douglas S Hanniford from San Francisco, CA, age 46

Compositions And Methods For Diagnosing And Treating Melanoma
view source
US Patent:

20090238896, Sep 24, 2009
Filed:

Mar 24, 2009
Appl. No.:

12/410348
Inventors:

EVA HERNANDO - NEW YORK NY, US
MIGUEL F. SEGURA - NEW YORK NY, US
DOUGLAS HANNIFORD - NEW YORK NY, US
SILVIA MENENDEZ - NEW YORK NY, US
Assignee:

NEW YORK UNVERSITY - NEW YORK NY
International Classification:

A61K 33/24
A61K 31/7105
A61K 31/704
A61K 38/12
C12Q 1/68
A61P 35/00
C07H 21/02
US Classification:

424649, 514 44 R, 514 34, 514 10, 435 6, 536 241, 536 245
Abstract:

Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.

Compositions And Methods For Diagnosing And Treating Melanoma
view source
US Patent:

20120322743, Dec 20, 2012
Filed:

Aug 8, 2012
Appl. No.:

13/569845
Inventors:

Eva Hernando - New York NY, US
Miguel F. Segura - New York NY, US
Douglas Hanniford - New York NY, US
Silvia Menendez - New York NY, US
Assignee:

NEW YORK UNIVERSITY - New York NY
International Classification:

A61K 31/7088
A61P 35/00
C07H 21/02
C40B 30/04
A61K 38/12
C12Q 1/68
US Classification:

514 199, 514 44 A, 514 34, 435 612, 536 2431, 506 9
Abstract:

Described herein are compositions and methods for the diagnosis, prognosis, prevention and treatment of melanoma or melanoma associated symptoms. The compositions are microRNA molecules associated with melanoma, as well as various nucleic acid molecules relating thereto or derived therefrom.

Method For Predicting Development Of Melanoma Brain Metastasis
view source
US Patent:

20160298198, Oct 13, 2016
Filed:

Nov 13, 2014
Appl. No.:

15/036718
Inventors:

- New York NY, US
Douglas Hanniford - New York NY, US
Hua Zhong - Short Hills NJ, US
Iman Osman - Jersey City NJ, US
Assignee:

New York University - New York NY
International Classification:

C12Q 1/68
A61K 31/506
A61N 5/10
C12N 15/113
A61K 31/7105
A61K 31/437
C07K 16/28
Abstract:

The invention relates to miRNA-based methods for prognosis of melanoma brain metastasis and related methods and kits. In one embodiment, the invention provides a method for predicting the likelihood of developing melanoma brain metastasis (B-Met) in a subject diagnosed with primary melanoma, said method comprising determining the levels of miR-150-5p, miR-15b-5p, miR-16-5p, and miR-374b-3p in a primary melanoma sample collected from the subject.

Douglas S Hanniford